| Market revenue in 2023 | USD 124.5 million |
| Market revenue in 2030 | USD 243.2 million |
| Growth rate | 10% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Software |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables, Software |
| Key market players worldwide | Natera Inc, 10x Genomics Inc Ordinary Shares - Class A, Dovetail Genomics, Illumina Inc, NanoString Technologies, Seven Bridges, Horizon Discovery, Bio-Techne Corp, S2 Genomics |
According to estimates by American Society of Cancer, 1,688,780 new cancer cases were reported in the U.S. in 2017. Moreover, ongoing strategic investments in cancer research have rendered the U.S. a global leader in the field. Cancer Prevention and Control Research Network is a flagship program initiated by CDC for prevention of cancer.
Through colorectal cancer prevention and control initiatives, CDC is conducting and promoting screening for colorectal cancer. Alzheimer’s disease is the sixth leading cause of death in the U.S. Therefore, increase in prevalence of chronic disorders in the U.S. is expected to drive demand for advanced diagnostic & treatment
Methods based on spatial genomics and transcriptomics. In addition, due to continuous development in technologies, a single tissue sample can now be used to detect multiple abnormalities. This has led to an increase in adoption of genomicsbased diagnosis techniques.
Publish Date: -
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Natera Inc | View profile | 3,293 | 13011 McCallen Pass, Building A Suite 100, Austin, TX, United States, 78753 | www.natera.com |
| Bio-Techne Corp | View profile | 3,050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | www.bio-techne.com |
| 10x Genomics Inc Ordinary Shares - Class A | View profile | 1,259 | 6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588 | www.10xgenomics.com |
| Horizon Discovery | View profile | 101-250 | Cambridge, Cambridgeshire, United Kingdom, Europe | www.horizondiscovery.com |
| Dovetail Genomics | View profile | 11-50 | Scotts Valley, California, United States, North America | dovetailgenomics.com/ |
| NanoString Technologies | View profile | 251-500 | Seattle, Washington, United States, North America | www.nanostring.com |
| Seven Bridges | View profile | 251-500 | Charlestown, Massachusetts, United States, North America | www.sevenbridges.com/ |
| S2 Genomics | View profile | 11-50 | Livermore, California, United States, North America | s2genomics.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Spatial Genomics & Transcriptomics Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 52.77% in 2023.
Horizon Databook has segmented the U.S. spatial genomics & transcriptomics market based on instruments, consumables, software covering the revenue growth of each sub-segment from 2018 to 2030.
According to estimates by American Society of Cancer, 1,688,780 new cancer cases were reported in the U.S. in 2017. Moreover, ongoing strategic investments in cancer research have rendered the U.S. a global leader in the field. Cancer Prevention and Control Research Network is a flagship program initiated by CDC for prevention of cancer.
Through colorectal cancer prevention and control initiatives, CDC is conducting and promoting screening for colorectal cancer. Alzheimer’s disease is the sixth leading cause of death in the U.S. Therefore, increase in prevalence of chronic disorders in the U.S. is expected to drive demand for advanced diagnostic & treatment
Methods based on spatial genomics and transcriptomics. In addition, due to continuous development in technologies, a single tissue sample can now be used to detect multiple abnormalities. This has led to an increase in adoption of genomicsbased diagnosis techniques.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Spatial Genomics & Transcriptomics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Spatial Genomics & Transcriptomics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
